.
Recently, we have used mice that specifically expressed the GFP and YFP proteins in NK cells and DCs respectively to visualize NK cell priming upon i.v administration of poly I:C.
We found that NK cells become activated while maintaining a migratory behavior, in the absence of long-lived contacts with DCs 10 .
While i.v poly I:C administration mimics certain aspects of systemic viral infections, the sequence of events mediating NK cell activation in response to lymph-borne viral particles has not been identified. This is particularly relevant because viruses delivered locally (through insect bites for example) are expected to reach the lymph 11 and as the local delivery of viralbased vector is being used for vaccination purposes 12 . To address this issue, we analyzed and imaged by two-photon microscopy NK cell activation in response to subcutaneous delivery of recombinant Modified Vaccinia virus Ankara (MVA), an attractive viral vector that is being considered for vaccination against cancer and infectious diseases 12 13 . We used a clinical grade MVA preparation, termed MVA-HIV, developed by the ANRS, (the french National
Agency against AIDS and Hepatitis), and expressing HIV Gag Pol and Nef antigens. We 
Injections.
Recombinant MVA expressing an HIV polyprotein (containing full length Gag, fused to three Pol and two Nef fragments) has been described previously 14 and was provided by the ANRS.
Mice were injected in the footpad with 5x10 6 pfu of MVA or 50μg Poly I:C (Invivogen).
Clodronate was encapsulated in liposomes as described earlier 17 . For macrophage depletion, analyzed using the FlowJo software (version 9.1, Tree Star). For measurement of IFN-α levels, intact lymph nodes were cultured at 37°C for 16 h. Cytokine production in the supernatant was measured using a mouse IFN−α platinum ELISA kit (eBioscience) following the manufacturer's instructions.
Two-photon imaging.
Two-photon imaging of intact popliteal lymph node was performed as described previously 18 on a upright microscope (DM6000B, Leica Microsystems) with a 20X/0.95 NA water-dipping objective (Olympus). Excitation was provided by a Chameleon Ultra Ti:Sapphire (Coherent) tuned at 960 nm. Datasets were processed and analyzed using Imaris (Bitplane) and the custom designed DISCit software for conversion into FCS files. Imaging data were then displayed using FlowJo software as dot plot profiles and histograms.
Statistical analyses.
All data are represented as mean ± SEM. Statistical analyses were performed using Prism software (GraphPad) and unpaired Student's t test, Mann Whitney or one-way ANOVA test.
P-values lower than 0.05 were considered significant and noted as *, values lower than 0.01 and 0.001 were noted as ** and *** respectively.
Results

Local delivery of MVA induces NK cell recruitment and activation in the draining lymph node
In order to study how lymph node NK cells sense lymph borne viral particles, we injected C57BL/6 mice in the footpad with a recombinant MVA virus (5x10 6 pfu), a vaccine candidate against HIV developed by the ANRS (hereafter referred to as MVA). We found that 16 h after MVA administration, NK cells in the draining lymph node increased by tenfold in absolute numbers and by threefold in percentage (Fig. 1A) . In order to better define the cues that promoted NK cell accumulation in the draining lymph node, we analyzed the response of mice deficient for either CXCR3 or CCR5, two chemokine receptors that were previously shown to contribute to NK cell trafficking. Interestingly, CXCR3 -/-but no CCR5 -/-recipients displayed a dampened NK cell accumulation as compared to WT animals ( Fig. 1B-C ).
Altogether our results indicates that MVA induces a sizeable increase in NK cell numbers in the draining lymph node that was partly dependent on the CXCR3 receptor.
Next, we assessed whether NK cells accumulating in the draining lymph nodes became activated upon MVA injection. We found that, at 16 h, lymph node NK cells upregulated the CD69 activation marker and displayed a strong increase in intracellular granzyme B content ( 
MVA induces accumulation of NK cells in the subcapsular area of the lymph node
To assess how local delivery of virus particles may influence NK cell behavior, we analyzed NK cell dynamics in lymph nodes. We injected PBS or MVA in the footpad of NCR1
GFP/+ mice, in which all NK cells are specifically fluorescently labeled 16 and performed two-photon imaging on intact popliteal lymph nodes. In control mice, NK cells were motile and mostly enriched in the interfollicular/outer T cell zone of the lymph nodes as described previously 10, 19, 20 . Interestingly, a large fraction of NK cells redistributed to the subcapsular area in MVA treated mice (Fig. 3A-B , movie S1). To quantify this phenomenon, we took advantage of DISC, a methodology that we have recently developed in which imaging datasets are processed, converted into an FCS file and subjected to multiparametric analysis using a flow cytometry software 21 . Through gating strategies, DISC allowed us to quantify NK cell distribution and velocity in distinct locations of the lymph node. As shown in 3E, movieS2) . Interestingly, we found that CD169 + macrophages were no longer detected in the draining lymph node at 48h while the bulk of CD11b + cells was not affected and this effect was independent of IFNAR signaling (Fig. S3) . To test if NK cells were killing SCS macrophages, we examined IL15 -/-mice that lack NK cells. We found that SCS macrophages also disappeared in IL15 -/-mice upon MVA administration (Fig. S3) suggesting that SCS (Fig. 4A-B) . As shown in Fig. 4C-F showing normal upregulation of CD69 and granzyme B (Fig. 4E-F) . This result indicates that NK cells from CL-treated mice remain responsive to activating signals, excluding a nonspecific effect of CL on NK cell functions.
Next, we examined the contribution of SCS macrophages to type I IFN production. We found that MVA resulted in an increased production of type I IFN in the lymph nodes but that CLtreatment abolished this production (Fig. S4) (Fig. S5) . These results highlight the importance of type I IFN signaling on accessory cells to promote NK cells activation.
Altogether, our results suggest that CD169 + subcapsular macrophages are critical for NK cell activation by lymph-borne viral particles but dispensable for activation by the doublestranded RNA analog, poly I:C.
Subcapsular macrophages are required for NK cell redistribution and deceleration in SCS areas
Finally, we assessed whether SCS macrophages are required for the observed changes in NK cell distribution and motility in the lymph node draining the site of MVA injection. To this
For personal use only. on October 28, 2017. by guest www.bloodjournal.org From 11 end, we performed two-photon imaging of lymph nodes from CL-treated mice, 16 h after MVA administration. As shown in Fig. 5 and movie S3, CL-treatment virtually abolished NK cell accumulation in SCS areas (Fig. 5A-B) . In addition, the marked deceleration of NK cells in SCS areas was also largely attenuated (Fig. 5C-D) . These results strongly suggest that, in response to MVA, SCS macrophages promote the recruitment and deceleration of NK cells in SCS areas. We propose that SCS macrophages are essential for the NK cell response to lymph-borne viral particles. [31] [32] [33] , we show here that lymph-borne viral particles profoundly alter NK cell numbers and distribution in lymph nodes and that these effects are dependent on SCS macrophages. Moreover, depletion of SCS macrophages abolished NK cell activation in response to MVA but not to poly I:C. Therefore, it appears that distinct cell types contribute to NK cell activation depending on the nature of the stimulus and/or on its route of delivery.
Future studies should help determine whether SCS macrophages contribute to NK cell activation seen in response to other pathogens such as Leishmania major 34 .
MVA is a single-cycle, non replicating virus that is currently being used as a candidate vaccine in various clinical trials 12, 13 . Our results suggest that SCS macrophages could play an important role in the response to such vaccine candidates. In our study, we used a recombinant MVA developed by the ANRS, to elicit T cell responses against HIV epitopes 14 , and which will soon enter into phase I clinical trial. Our present work demonstrates that SCS macrophages have a profound impact on the lymph node microenvironment and the innate immune response upon MVA administration. Future work will help assessing whether SCS macrophages contribute to the adaptive immune response and the generation of T cell responses. Moreover, our approach illustrates how in vivo imaging allows dissecting the early effects and mode of action of vaccine candidates with a high spatiotemporal resolution.
Importantly, our results extend the list of recently identified functions for SCS macrophages.
Indeed, these cells have been shown to present viral particles to B cells 11 and to prevent VSV from gaining access to peripheral nerves 35 . SCS macrophages have also been implicated in antigen-presentation to T cells in response to vaccinia virus 36 , Toxoplama Gondii 37 or tumors 38 and in NKT cell activation by lipid antigen 39 . Thus, by sensing lymph content in lymph nodes, SCS macrophages appear to play a pivotal role in the initiation of both innate and adaptive immune responses.
Imaging the dynamics of MVA-induced NK cell activation revealed striking differences with the behavior of NK cells following systemic delivery of poly I:C that we had previously 
